Old Web
English
Sign In
Acemap
>
Paper
>
Rationale and Design of the Vasospastic Angina Treatment by Endothelin Receptor Antagonism (VERA) Trial
Rationale and Design of the Vasospastic Angina Treatment by Endothelin Receptor Antagonism (VERA) Trial
2021
Rutger Feenstra
Matthijs Boekholdt
Yolande Appelman
Peter Damman
Marianne E. Wittekoek
Robbert J. de Winter
Tim P. van de Hoef
Jan Piek
Marcel A.M. Beijk
Keywords:
Endothelin receptor
Antagonism
Pharmacology
Vasospastic angina
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]